🇺🇸 ClinSupV3ER- Extended release tablet in United States

ClinSupV3ER- Extended release tablet (ClinSupV3ER- Extended release tablet) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

ClinSupV3ER- Extended release tablet in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ClinSupV3ER- Extended release tablet approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for ClinSupV3ER- Extended release tablet in United States?

Dr Bharti Daswani is the originator. The local marketing authorisation holder may differ — check the official source linked above.